Cosmos Health Inc. - Common Stock (NQ:COSM)

0.2531 -0.0079 (-3.03%)

Streaming Delayed Price Updated: 12:59 PM EDT, Jun 3, 2026 Add to My Watchlist

Price and Volume

Volume	1,081,352
Open	0.2687
Bid (Size)	0.2515 (8,000)
Ask (Size)	0.2547 (200)
Prev. Close	0.2610
Today's Range	0.2452 - 0.2687
52wk Range	0.2464 - 1.320
Shares Outstanding	34,919,920
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price

June 02, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

June 01, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Performance

YTD	-50.9%	-50.9%
1 Month	-29.1%	-29.1%
3 Month	-33.9%	-33.9%
6 Month	-54.0%	-54.0%
1 Year	-44.9%	-44.9%

More News

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

May 26, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026

Via ACCESS Newswire

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

May 21, 2026

Via ACCESS Newswire

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026

Via ACCESS Newswire

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 12, 2026

Via ACCESS Newswire

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 11, 2026

Via ACCESS Newswire

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 08, 2026

Via ACCESS Newswire

Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness

May 06, 2026

Via ACCESS Newswire

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

April 30, 2026

Via ACCESS Newswire

Top movers in Friday's after hours session ↗

April 24, 2026

Via Chartmill

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

April 21, 2026

Via ACCESS Newswire

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

April 20, 2026

Via ACCESS Newswire

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

April 17, 2026

Via ACCESS Newswire

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

April 16, 2026

Via Chartmill

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

April 16, 2026

Via ACCESS Newswire

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into

April 15, 2026

Via ACCESS Newswire

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

April 13, 2026

Via ACCESS Newswire

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

April 10, 2026

Via ACCESS Newswire

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

April 01, 2026

Via ACCESS Newswire

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue

March 19, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

March 11, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

March 10, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

February 24, 2026

From Cosmos Health Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Cosmos Health Inc. - Common Stock publicly traded?

Yes, Cosmos Health Inc. - Common Stock is publicly traded.

What exchange does Cosmos Health Inc. - Common Stock trade on?

Cosmos Health Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cosmos Health Inc. - Common Stock?

The ticker symbol for Cosmos Health Inc. - Common Stock is COSM on the Nasdaq Stock Market

What is the current price of Cosmos Health Inc. - Common Stock?

The current price of Cosmos Health Inc. - Common Stock is 0.2531

When was Cosmos Health Inc. - Common Stock last traded?

The last trade of Cosmos Health Inc. - Common Stock was at 06/03/26 12:59 PM ET

What is the market capitalization of Cosmos Health Inc. - Common Stock?

The market capitalization of Cosmos Health Inc. - Common Stock is 8.84M

How many shares of Cosmos Health Inc. - Common Stock are outstanding?

Cosmos Health Inc. - Common Stock has 9M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.